Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-25, Stock:PFE, The news for the past five days is as follows:
2020-06-18: NEWS1: Dow's 39-point drop led by losses for shares of American Express, Goldman Sachs.NEWS2: Dow's 39-point drop led by losses for shares of American Express, Goldman Sachs.NEWS3: American Express, Pfizer share losses lead Dow's 110-point fall.NEWS4: Dow's 38-point drop led by losses in shares of American Express, Cisco.NEWS5: Dow's 38-point drop led by losses in shares of American Express, Cisco.NEWS6: Dow falls 39 points on losses in shares of UnitedHealth, Cisco.NEWS7: Pfizer's hemophilia gene therapy shows sustained effect in early-stage study.NEWS8: Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy.NEWS9: Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Factor VIII Activity Levels and No Bleeding Events or Factor Usage in 3e13 vg/kg Cohort Following giroctocogene fitelparvovec (SB-525) Gene Therapy.NEWS10: Upjohn Announces Pricing of Senior Notes in Connection with the Proposed Combination of Mylan and Upjohn.
2020-06-19: NEWS1: Upjohn Finance B.V. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' Euro notes offering; outlook stable.NEWS2: Upjohn Inc. -- Moody's assigns Baa3 unsecured rating to Upjohn/Viatris' US notes offering; outlook stable.
2020-06-22: NEWS1: Coronavirus Latest: Monday, June 22.NEWS2: Dow flat in spite of losses in Walgreens Boots, Merck shares.NEWS3: Pfizer Announces Start of Four Phase 3 Clinical Trials for Investigational Vaccines.
2020-06-23: NEWS1: Sarepta Addressing Gene Therapy Issue With Two Acquisitions.NEWS2: The Promise and Perils of Owning Pfizer.NEWS3: Merck's Pneumococcal Vaccine Meets Goal in Two Adult Studies.NEWS4: Pfizer Begins Four Phase III Studies on Vaccine Candidates.NEWS5: Oncolytics Biotech® Doses First Patient in Phase 2 BRACELET-1 Study Evaluating Pelareorep-Based Combination Therapies in Metastatic Breast Cancer.NEWS6: Sanofi eyes approval of COVID-19 vaccine by first half of 2021.
2020-06-24: NEWS1: FuelCell Energy: Rising From the Brink of Bankruptcy.NEWS2: Pfizer and Wellcome Launch Surveillance Program to Combat Growing Threat of Antimicrobial Resistance in Sub-Saharan Africa.

Answer: Rise